Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC

Wang, Q., Guo, Y., Mellis, I. A., Wu, M., Mohri, H., Gherasim, C., Valdez, R., Purpura, L. J., Yin, M. T., Gordon, A., & Ho, D. D. (2025). Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC. Cell Reports, 44(4), 115543. https://doi.org/10.1016/j.celrep.2025.115543
Authors:
Qian Wang
Yicheng Guo
Ian A Mellis
Madeline Wu
Hiroshi Mohri
Carmen Gherasim
Riccardo Valdez
Lawrence J Purpura
Michael T Yin
Aubree Gordon
David D Ho
Affiliated Authors:
Qian Wang
Yicheng Guo
Ian A Mellis
Madeline Wu
Hiroshi Mohri
Lawrence J Purpura
Michael T Yin
David D Ho
Columbia Affiliation:
Subjects:
SARS-CoV-2 (MeSH)
Antibodies, Neutralizing (MeSH)
Antibodies, Viral (MeSH)
COVID-19 (MeSH)
Author Keywords:
ace2 inhibition
antibody evasion
cp: immunology
cp: microbiology
jn.1 subvariants
kp.3.1.1
monoclonal antibodies
mrna vaccines
sars-cov-2
serum neutralization
xec
elink
Publication Type:
Article
Unique ID:
10.1016/j.celrep.2025.115543
PMID:
40202847
DOI:
10.1016/j.celrep.2025.115543
Journal:
Cell Reports
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: